| DC Field | Value | Language |
|---|
| dc.contributor.author | Yakushev, V. I. | - |
| dc.contributor.author | Filippenko, N. G. | - |
| dc.contributor.author | Kizilova, I. V. | - |
| dc.contributor.author | Korokin, M. V. | - |
| dc.contributor.author | Beskhmelnitsyna, E. A. | - |
| dc.date.accessioned | 2022-04-26T08:05:34Z | - |
| dc.date.available | 2022-04-26T08:05:34Z | - |
| dc.date.issued | 2016 | - |
| dc.identifier.citation | Studying dose-dependent endothelio- and cardioprotective activity of selective arginase II inhibitor in hyperhomocysteineinduced endothelial dysfunction / V.I. Yakushev [et al.] // Research Result: Pharmacology and Clinical Pharmacology. - 2016. - Vol. 2, № 1(2).- P. 42-45. - Doi: 10.18413/2313-8971-2016-2-1-42-45. - Refer.: p. 44-45. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46357 | - |
| dc.description.abstract | This paper deals with the study of endothelio- and cardioprotective activity ofarginase II selective inhibitor, the substance under the code ZB49-0010C in the model of hyperhomocysteine-induced endothelial dysfunction | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | endothelial dysfunction | ru |
| dc.subject | a selective inhibitor | ru |
| dc.subject | arginase II | ru |
| dc.subject | nitric oxide | ru |
| dc.subject | methionine | ru |
| dc.subject | homocysteine | ru |
| dc.title | Studying dose-dependent endothelio- and cardioprotective activity of selective arginase II inhibitor in hyperhomocysteineinduced endothelial dysfunction | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 2, № 1
|
